Listen to music while browsing

Johnson & Johnson fined $1.1bn in latest Risperdal case

By BBC

Drugs giant Johnson & Johnson (J&J) has been ordered by a US judge to pay $1.1bn (£690m) for downplaying the risks involved in taking its anti-psychotic drug Risperdal.

The state of Arkansas sued J&J and its subsidiary Janssen Pharmaceuticals over its marketing of the drug in 2007.

A number of US states have already found the firms guilty of similar charges and fined them accordingly.

Janssen said it was "disappointed" with the judge's decision.

The company added that if its motion for a retrial was denied, it would appeal the fine.

"During the nearly three-week trial, Janssen presented abundant evidence showing the company acted responsibly and fully complied with all laws and regulations regarding Risperdal," it said in a written statement.

Appeal
In January, J&J agreed to pay $158m to settle allegations of illegal marketing of Risperdal in Texas.

Last year, a South Carolina judge ruled the company must pay a $327m penalty after a jury found it guilty of similar charges, while in 2010, a Louisiana jury found the company violated the state's Medicaid fraud act.

These two verdicts are currently under appeal.
Medicaid is a government-backed US public heath programme for low-income citizens.

Expect Load Shedding To Continue For The Next Two Months - Gridco

Wednesday, January 28, 2015 If you were hoping an end was in sight for the ongoing erratic load shedding, then you may have to r ...

Ghana Will Lose Out If It Fails To Pass Plant Breeders Rights Bill - Researchers

Wednesday, January 28, 2015 Local farmers and others in the agricultural value chain need new technologies to boost food product ...
show more stories